{'52WeekChange': 0.12853336,
 'SandP52WeekChange': 0.0644362,
 'address1': '26 Landsdowne Street',
 'address2': '2nd Floor',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 21.99,
 'askSize': 900,
 'averageDailyVolume10Day': 215700,
 'averageVolume': 290641,
 'averageVolume10days': 215700,
 'beta': None,
 'beta3Year': None,
 'bid': 21.01,
 'bidSize': 3000,
 'bookValue': 5.326,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cambridge',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 21.8599,
 'dayLow': 20.85,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -14.252,
 'enterpriseToRevenue': 51387.227,
 'enterpriseValue': 1233293440,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 26.138857,
 'fiftyTwoWeekHigh': 31.8,
 'fiftyTwoWeekLow': 13,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 24304425,
 'forwardEps': -2.52,
 'forwardPE': -8.396826,
 'fromCurrency': None,
 'fullTimeEmployees': 87,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.13614,
 'heldPercentInstitutions': 0.23312001,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/beamtx.com',
 'longBusinessSummary': 'Beam Therapeutics Inc., a biotechnology company, '
                        'engages in developing precision genetic medicines for '
                        'patients suffering from serious diseases in the '
                        'United States. The company is developing therapies '
                        'for the development of sickle cell disease and '
                        'beta-thalassemia; CAR-T cell therapies for pediatric '
                        'T-cell acute lymphoblastic leukemia and pediatric '
                        'acute myeloid leukemia; therapies for alpha-1 '
                        'antitrypsin deficiency and glycogen storage disorder '
                        '1A; and therapies for ocular and central nervous '
                        'system disorders. It has a research and clinical '
                        'collaboration agreement with Magenta Therapeutics, '
                        'Inc. Beam Therapeutics Inc. was founded in 2017 and '
                        'is based in Cambridge, Massachusetts.',
 'longName': 'Beam Therapeutics Inc.',
 'market': 'us_market',
 'marketCap': 1089424768,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_564610577',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1561852800,
 'navPrice': None,
 'netIncomeToCommon': -106202000,
 'nextFiscalYearEnd': 1640908800,
 'open': 21.72,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '857 327 8775',
 'previousClose': 21.91,
 'priceHint': 2,
 'priceToBook': 3.9729626,
 'priceToSalesTrailing12Months': 45392.7,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 21.8599,
 'regularMarketDayLow': 20.85,
 'regularMarketOpen': 21.72,
 'regularMarketPreviousClose': 21.91,
 'regularMarketPrice': 21.72,
 'regularMarketVolume': 122261,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 49663100,
 'sharesPercentSharesOut': 0.0355,
 'sharesShort': 1826125,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1126038,
 'shortName': 'Beam Therapeutics Inc.',
 'shortPercentOfFloat': 0.051999997,
 'shortRatio': 5.18,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'BEAM',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -8.354,
 'twoHundredDayAverage': 22.189915,
 'volume': 122261,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.beamtx.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02139'}